Literature DB >> 7708120

Involvement of alpha-adrenoceptors in the excitatory effect of the A2 adenosine receptors agonist 5'-N-ethylcarboxamidoadenosine (NECA) on cardiac automaticity in the isolated right ventricle of the rat.

J Hernández1, F Pinto, J A Ribeiro.   

Abstract

The effects of the non-selective A2 adenosine receptor agonist 5'-N-ethyl-carboxamidoadenosine (NECA) were studied on ventricular automaticity induced by a local injury in the isolated right ventricle of the rat. In concentrations ranging from 0.1 to 100 nM, NECA significantly increased ventricular automaticity. This effect was not apparent when the nonselective alpha-adrenoceptor blocker phenoxybenzamine was present at a concentration of 10 microM, which antagonizes both alpha 1- and alpha 2-adrenoceptors, as well as when rats were pretreated with reserpine. In non-reserpinized rats, the excitatory effect of NECA was also abolished in the presence of the selective alpha 1-adrenoceptor antagonist prazosin, but not in the presence of the alpha 2-adrenoceptor antagonist idazoxan. In reserpinized rats, the excitatory effect of NECA was restored in the presence of the non specific alpha-adrenoceptor agonist phenylephrine as well as in the presence of the selective alpha 1-adrenoceptor agonist amidephrine but not in the presence of the selective alpha 2-adrenoceptor agonist clonidine. These results suggest that the excitatory effect of NECA on ectopic ventricular automaticity is dependent on endogenous catecholamines and that alpha-adrenoceptors of type 1 are, in some way, involved in this effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7708120     DOI: 10.1007/bf00169368

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

Review 1.  Existence and functional role of alpha 1-adrenoceptors in the mammalian heart.

Authors:  R Brückner; A Mügge; H Scholz
Journal:  J Mol Cell Cardiol       Date:  1985-07       Impact factor: 5.000

2.  Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias.

Authors:  A C Rankin; K G Oldroyd; E Chong; J W Dow; A P Rae; S M Cobbe
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

Review 3.  Adrenergic receptors in the heart.

Authors:  B B Hoffman; R J Lefkowitz
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

4.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Specific alpha 1-adrenergic receptor subtypes modulate catecholamine-induced increases and decreases in ventricular automaticity.

Authors:  U del Balzo; M R Rosen; G Malfatto; L M Kaplan; S F Steinberg
Journal:  Circ Res       Date:  1990-12       Impact factor: 17.367

6.  Effects of adenosine and its analogues on ventricular automaticity induced by a local injury: role of catecholamines and of cyclic AMP.

Authors:  J Hernández; M L Laorden; F Ruiz; J A Ribeiro
Journal:  Arch Int Pharmacodyn Ther       Date:  1989 Jan-Feb

7.  Alpha 1-adrenergic blockade raises epinephrine-arrhythmia threshold in halothane-anesthetized dogs in a dose-dependent fashion.

Authors:  M Maze; E Hayward; D M Gaba
Journal:  Anesthesiology       Date:  1985-12       Impact factor: 7.892

8.  A pertussis toxin substrate regulates alpha 1-adrenergic dependent phosphatidylinositol hydrolysis in cultured rat myocytes.

Authors:  S F Steinberg; Y K Chow; R B Robinson; J P Bilezikian
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

9.  Transient bradycardia and subsequent sinus tachycardia produced by intravenous adenosine in healthy adult subjects.

Authors:  A H Watt; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

10.  Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; J D Hartman; S J Hays; C C Huang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.